|
|
|
1
|
Citterio C, Jones HD, Pacheco-Rodriguez G, Islam A, Moss J, Vaughan M.
Effect of protein kinase A on accumulation of brefeldin A-inhibited guanine nucleotide-exchange protein 1 (BIG1) in HepG2 cell nuclei.
Proc Natl Acad Sci U S A: 2006.
[Text Abstract on PubMed]
|
|
|
2
|
Hiroi T, Someya A, Thompson W, Moss J, Vaughan M.
GEP100/BRAG2: Activator of ADP-ribosylation factor 6 for regulation of cell adhesion and actin cytoskeleton via E-cadherin and {alpha}-catenin.
Proc Natl Acad Sci U S A: 2006.
[Text Abstract on PubMed]
|
|
|
3
|
Shen X, Xu KF, Fan Q, Pacheco-Rodriguez G, Moss J, Vaughan M.
Association of brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2) with recycling endosomes during transferrin uptake.
Proc Natl Acad Sci U S A: 2006.
[Text Abstract on PubMed]
|
|
|
4
|
Jones HD, Moss J, Vaughan M.
BIG1 and BIG2, Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factors for ADP-Ribosylation Factors.
Methods Enzymol 404: 174-84, 2005.
[Text Abstract on PubMed]
|
|
|
5
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
Cytohesin-1: Structure, Function, and ARF Activation.
Methods Enzymol 404: 184-95, 2005.
[Text Abstract on PubMed]
|
|
|
6
|
Vichi A, Moss J, Vaughan M.
ADP-Ribosylation Factor Domain Protein 1 (ARD1), a Multifunctional Protein with Ubiquitin E3 Ligase, GAP, and ARF Domains.
Methods Enzymol 404: 195-206, 2005.
[Text Abstract on PubMed]
|
|
|
7
|
Vichi A, Payne DM, Pacheco-Rodriguez G, Moss J, Vaughan M.
E3 ubiquitin ligase activity of the trifunctional ARD1 (ADP-ribosylation factor domain protein 1).
Proc Natl Acad Sci U S A 102(6): 1945-50, 2005.
[Text Abstract on PubMed]
|
|
|
8
|
Xu KF, Shen X, Li H, Pacheco-Rodriguez G, Moss J, Vaughan M.
Interaction of BIG2, a brefeldin A-inhibited guanine nucleotide-exchange protein, with exocyst protein Exo70.
Proc Natl Acad Sci U S A 102(8): 2784-9, 2005.
[Text Abstract on PubMed]
|
|
|
9
|
Padilla PI, Pacheco-Rodriguez G, Moss J, Vaughan M.
Nuclear localization and molecular partners of BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
Proc Natl Acad Sci U S A 101(9): 2752-7, 2004.
[Text Abstract on PubMed]
|
|
|
10
|
Li H, Adamik R, Pacheco-Rodriguez G, Moss J, Vaughan M.
Protein kinase A-anchoring (AKAP) domains in brefeldin A-inhibited guanine nucleotide-exchange protein 2 (BIG2).
Proc Natl Acad Sci U S A 100(4): 1627-32, 2003.
[Text Abstract on PubMed]
|
|
|
11
|
Meacci E, Nuti F, Catarzi S, Vasta V, Donati C, Bourgoin S, Bruni P, Moss J, Vaughan M.
Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways.
Biochemistry 42(2): 284-92, 2003.
[Text Abstract on PubMed]
|
|
|
12
|
Moss J, Vaughan M.
Cytohesin-1 in 2001.
Arch Biochem Biophys 397(2): 156-61, 2002.
[Text Abstract on PubMed]
|
|
|
13
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
ARF-directed guanine-nucleotide-exchange (GEP) proteins.
Methods Mol Biol 189: 181-9, 2002.
[Text Abstract on PubMed]
|
|
|
14
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
Isolation, cloning, and characterization of brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factor.
Methods Enzymol 329: 300-6, 2001.
[Text Abstract on PubMed]
|
|
|
15
|
Pacheco-Rodriguez G, Moss J, Vaughan M.
Preparation and assay of recombinant ADP-ribosylation factor-like protein-1 (ARL1).
Methods Enzymol 329: 424-8, 2001.
[Text Abstract on PubMed]
|
|
|
16
|
Someya A, Sata M, Takeda K, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.
ARF-GEP(100), a guanine nucleotide-exchange protein for ADP-ribosylation factor 6.
Proc Natl Acad Sci U S A 98(5): 2413-8, 2001.
[Text Abstract on PubMed]
|
|
|
17
|
Vitale N, Moss J, Vaughan M.
Purification and properties of ARD1, an ADP-ribosylation factor (ARF)-related protein with GTPase-activating domain.
Methods Enzymol 329: 324-34, 2001.
[Text Abstract on PubMed]
|
|
|
18
|
Ogasawara M, Kim SC, Adamik R, Togawa A, Ferrans VJ, Takeda K, Kirby M, Moss J, Vaughan M.
Similarities in function and gene structure of cytohesin-4 and cytohesin-1, guanine nucleotide-exchange proteins for ADP-ribosylation factors.
J Biol Chem 275(5): 3221-30, 2000.
[Text Abstract on PubMed]
|
|
|
19
|
Vitale N, Ferrans VJ, Moss J, Vaughan M.
Identification of lysosomal and Golgi localization signals in GAP and ARF domains of ARF domain protein 1.
Mol Cell Biol 20(19): 7342-52, 2000.
[Text Abstract on PubMed]
|
|
|
20
|
Vitale N, Pacheco-Rodriguez G, Ferrans VJ, Riemenschneider W, Moss J, Vaughan M.
Specific functional interaction of human cytohesin-1 and ADP-ribosylation factor domain protein (ARD1).
J Biol Chem 275(28): 21331-9, 2000.
[Text Abstract on PubMed]
|
|
|
21
|
Vitale N, Patton WA, Moss J, Vaughan M, Lefkowitz RJ, Premont RT.
GIT proteins, A novel family of phosphatidylinositol 3,4, 5-trisphosphate-stimulated GTPase-activating proteins for ARF6.
J Biol Chem 275(18): 13901-6, 2000.
[Text Abstract on PubMed]
|
|
|
22
|
Yamaji R, Adamik R, Takeda K, Togawa A, Pacheco-Rodriguez G, Ferrans VJ, Moss J, Vaughan M.
Identification and localization of two brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors in a macromolecular complex.
Proc Natl Acad Sci U S A 97(6): 2567-72, 2000.
[Text Abstract on PubMed]
|
|
|
23
|
Meacci E, Vasta V, Moorman JP, Bobak DA, Bruni P, Moss J, Vaughan M.
Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells.
J Biol Chem 274(26): 18605-12, 1999.
[Text Abstract on PubMed]
|
|
|
24
|
Morinaga N, Adamik R, Moss J, Vaughan M.
Brefeldin A inhibited activity of the sec7 domain of p200, a mammalian guanine nucleotide-exchange protein for ADP-ribosylation factors.
J Biol Chem 274(25): 17417-23, 1999.
[Text Abstract on PubMed]
|
|
|
25
|
Moss J, Vaughan M.
Activation of toxin ADP-ribosyltransferases by eukaryotic ADP-ribosylation factors.
Mol Cell Biochem 193(1-2): 153-7, 1999.
[Text Abstract on PubMed]
|
|
|
26
|
Pacheco-Rodriguez G, Patton WA, Adamik R, Yoo HS, Lee FJ, Zhang GF, Moss J, Vaughan M.
Structural elements of ADP-ribosylation factor 1 required for functional interaction with cytohesin-1.
J Biol Chem 274(18): 12438-44, 1999.
[Text Abstract on PubMed]
|
|
|
27
|
Sata M, Moss J, Vaughan M.
Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors.
Proc Natl Acad Sci U S A 96(6): 2752-7, 1999.
[Text Abstract on PubMed]
|
|
|
28
|
Stevens LA, Moss J, Vaughan M, Pizza M, Rappuoli R.
Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors.
Infect Immun 67(1): 259-65, 1999.
[Text Abstract on PubMed]
|
|
|
29
|
Togawa A, Morinaga N, Ogasawara M, Moss J, Vaughan M.
Purification and cloning of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP-ribosylation factors.
J Biol Chem 274(18): 12308-15, 1999.
[Text Abstract on PubMed]
|
|
|
30
|
Hong JX, Lee FJ, Patton WA, Lin CY, Moss J, Vaughan M.
Phospholipid- and GTP-dependent activation of cholera toxin and phospholipase D by human ADP-ribosylation factor-like protein 1 (HARL1).
J Biol Chem 273(25): 15872-6, 1998.
[Text Abstract on PubMed]
|
|
|
31
|
Moss J, Vaughan M.
Molecules in the ARF orbit.
J Biol Chem 273(34): 21431-4, 1998.
[Text Abstract on PubMed]
|
|
|
32
|
Pacheco-Rodriguez G, Meacci E, Vitale N, Moss J, Vaughan M.
Guanine nucleotide exchange on ADP-ribosylation factors catalyzed by cytohesin-1 and its Sec7 domain.
J Biol Chem 273(41): 26543-8, 1998.
[Text Abstract on PubMed]
|
|
|
33
|
Premont RT, Claing A, Vitale N, Freeman JL, Pitcher JA, Patton WA, Moss J, Vaughan M, Lefkowitz RJ.
beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.
Proc Natl Acad Sci U S A 95(24): 14082-7, 1998.
[Text Abstract on PubMed]
|
|
|
34
|
Sata M, Donaldson JG, Moss J, Vaughan M.
Brefeldin A-inhibited guanine nucleotide-exchange activity of Sec7 domain from yeast Sec7 with yeast and mammalian ADP ribosylation factors.
Proc Natl Acad Sci U S A 95(8): 4204-8, 1998.
[Text Abstract on PubMed]
|
|
|
35
|
Tsai SC, Adamik R, Hong JX, Moss J, Vaughan M, Kanoh H, Exton JH.
Effects of arfaptin 1 on guanine nucleotide-dependent activation of phospholipase D and cholera toxin by ADP-ribosylation factor.
J Biol Chem 273(33): 20697-701, 1998.
[Text Abstract on PubMed]
|
|
|
36
|
Vaughan M.
Signaling by heterotrimeric G proteins minireview series.
J Biol Chem 273(2): 667-8, 1998.
[Text Abstract on PubMed]
|
|
|
37
|
Vitale N, Horiba K, Ferrans VJ, Moss J, Vaughan M.
Localization of ADP-ribosylation factor domain protein 1 (ARD1) in lysosomes and Golgi apparatus.
Proc Natl Acad Sci U S A 95(15): 8613-8, 1998.
[Text Abstract on PubMed]
|
|
|
38
|
Vitale N, Moss J, Vaughan M.
Molecular characterization of the GTPase-activating domain of ADP-ribosylation factor domain protein 1 (ARD1).
J Biol Chem 273(5): 2553-60, 1998.
[Text Abstract on PubMed]
|
|
|
39
|
Lee FJ, Huang CF, Yu WL, Buu LM, Lin CY, Huang MC, Moss J, Vaughan M.
Characterization of an ADP-ribosylation factor-like 1 protein in Saccharomyces cerevisiae.
J Biol Chem 272(49): 30998-1005, 1997.
[Text Abstract on PubMed]
|
|
|
40
|
Lee FJ, Patton WA, Lin CY, Moss J, Vaughan M, Goldman ND, Syin C.
Identification and characterization of an ADP-ribosylation factor in Plasmodium falciparum.
Mol Biochem Parasitol 87(2): 217-23, 1997.
[Text Abstract on PubMed]
|
|
|
41
|
Meacci E, Tsai SC, Adamik R, Moss J, Vaughan M.
Cytohesin-1, a cytosolic guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proc Natl Acad Sci U S A 94(5): 1745-8, 1997.
[Text Abstract on PubMed]
|
|
|
42
|
Morinaga N, Moss J, Vaughan M.
Cloning and expression of a cDNA encoding a bovine brain brefeldin A-sensitive guanine nucleotide-exchange protein for ADP-ribosylation factor.
Proc Natl Acad Sci U S A 94(24): 12926-31, 1997.
[Text Abstract on PubMed]
|
|
|
43
|
Vaughan M, Moss J.
Activation of toxin ADP-ribosyltransferases by the family of ADP-ribosylation factors.
Adv Exp Med Biol 419: 315-20, 1997.
[Text Abstract on PubMed]
|
|
|
44
|
Vitale N, Moss J, Vaughan M.
Characterization of a GDP dissociation inhibitory region of ADP-ribosylation factor domain protein ARD1.
J Biol Chem 272(40): 25077-82, 1997.
[Text Abstract on PubMed]
|
|
|
45
|
Vitale N, Moss J, Vaughan M.
Interaction of the GTP-binding and GTPase-activating domains of ARD1 involves the effector region of the ADP-ribosylation factor domain.
J Biol Chem 272(7): 3897-904, 1997.
[Text Abstract on PubMed]
|
|
|
46
|
Ding M, Vitale N, Tsai SC, Adamik R, Moss J, Vaughan M.
Characterization of a GTPase-activating protein that stimulates GTP hydrolysis by both ADP-ribosylation factor (ARF) and ARF-like proteins. Comparison to the ARD1 gap domain.
J Biol Chem 271(39): 24005-9, 1996.
[Text Abstract on PubMed]
|
|
|
47
|
Lee CM, Stevens LA, Hsu HC, Tsai SC, Lee YT, Moss J, Vaughan M.
Expression in human endothelial cells of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins involved in the initiation of vesicular transport.
J Mol Cell Cardiol 28(9): 1911-20, 1996.
[Text Abstract on PubMed]
|
|
|
48
|
Morinaga N, Tsai SC, Moss J, Vaughan M.
Isolation of a brefeldin A-inhibited guanine nucleotide-exchange protein for ADP ribosylation factor (ARF) 1 and ARF3 that contains a Sec7-like domain.
Proc Natl Acad Sci U S A 93(23): 12856-60, 1996.
[Text Abstract on PubMed]
|
|
|
49
|
Price SR, Nightingale MS, Tsuchiya M, Moss J, Vaughan M.
Interspecies relationships among ADP-ribosylation factors (ARFs): evidence of evolutionary pressure to maintain individual identities.
Mol Cell Biochem 159(1): 15-23, 1996.
[Text Abstract on PubMed]
|
|
|
50
|
Tsai SC, Adamik R, Moss J, Vaughan M.
Purification and characterization of a guanine nucleotide-exchange protein for ADP-ribosylation factor from spleen cytosol.
Proc Natl Acad Sci U S A 93(1): 305-9, 1996.
[Text Abstract on PubMed]
|
|
|
51
|
Vitale N, Moss J, Vaughan M.
ARD1, a 64-kDa bifunctional protein containing an 18-kDa GTP-binding ADP-ribosylation factor domain and a 46-kDa GTPase-activating domain.
Proc Natl Acad Sci U S A 93(5): 1941-4, 1996.
[Text Abstract on PubMed]
|
|
|
52
|
Hong JX, Zhang X, Moss J, Vaughan M.
Isolation of an amino-terminal deleted recombinant ADP-ribosylation factor 1 in an activated nucleotide-free state.
Proc Natl Acad Sci U S A 92(7): 3056-9, 1995.
[Text Abstract on PubMed]
|
|
|
53
|
Justice JM, Bliziotes MM, Stevens LA, Moss J, Vaughan M.
Involvement of N-myristoylation in monoclonal antibody recognition sites on chimeric G protein alpha subunits.
J Biol Chem 270(12): 6436-9, 1995.
[Text Abstract on PubMed]
|
|
|
54
|
Justice JM, Murtagh JJ, Moss J, Vaughan M.
Hydrophobicity and subunit interactions of rod outer segment proteins investigated using Triton X-114 phase partitioning.
J Biol Chem 270(30): 17970-6, 1995.
[Text Abstract on PubMed]
|
|
|
55
|
Moss J, Vaughan M.
Structure and function of ARF proteins: activators of cholera toxin and critical components of intracellular vesicular transport processes.
J Biol Chem 270(21): 12327-30, 1995.
[Text Abstract on PubMed]
|
|
|
56
|
Zhang GF, Patton WA, Lee FJ, Liyanage M, Han JS, Rhee SG, Moss J, Vaughan M.
Different ARF domains are required for the activation of cholera toxin and phospholipase D.
J Biol Chem 270(1): 21-4, 1995.
[Text Abstract on PubMed]
|
|
|
57
|
Hong JX, Haun RS, Tsai SC, Moss J, Vaughan M.
Effect of ADP-ribosylation factor amino-terminal deletions on its GTP-dependent stimulation of cholera toxin activity.
J Biol Chem 269(13): 9743-5, 1994.
[Text Abstract on PubMed]
|
|
|
58
|
Lee FJ, Stevens LA, Hall LM, Murtagh JJ, Kao YL, Moss J, Vaughan M.
Characterization of class II and class III ADP-ribosylation factor genes and proteins in Drosophila melanogaster.
J Biol Chem 269(34): 21555-60, 1994.
[Text Abstract on PubMed]
|
|
|
59
|
Lee FJ, Stevens LA, Kao YL, Moss J, Vaughan M.
Characterization of a glucose-repressible ADP-ribosylation factor 3 (ARF3) from Saccharomyces cerevisiae.
J Biol Chem 269(33): 20931-7, 1994.
[Text Abstract on PubMed]
|
|
|
60
|
Massenburg D, Han JS, Liyanage M, Patton WA, Rhee SG, Moss J, Vaughan M.
Activation of rat brain phospholipase D by ADP-ribosylation factors 1,5, and 6: separation of ADP-ribosylation factor-dependent and oleate-dependent enzymes.
Proc Natl Acad Sci U S A 91(24): 11718-22, 1994.
[Text Abstract on PubMed]
|
|
|
61
|
Murtagh JJ, Moss J, Vaughan M.
Alternative splicing of the guanine nucleotide-binding regulatory protein Go alpha generates four distinct mRNAs.
Nucleic Acids Res 22(5): 842-9, 1994.
[Text Abstract on PubMed]
|
|
|
62
|
Tsai SC, Adamik R, Moss J, Vaughan M.
Identification of a brefeldin A-insensitive guanine nucleotide-exchange protein for ADP-ribosylation factor in bovine brain.
Proc Natl Acad Sci U S A 91(8): 3063-6, 1994.
[Text Abstract on PubMed]
|
|
|
63
|
Welsh CF, Moss J, Vaughan M.
ADP-ribosylation factors: a family of approximately 20-kDa guanine nucleotide-binding proteins that activate cholera toxin.
Mol Cell Biochem 138(1-2): 157-66, 1994.
[Text Abstract on PubMed]
|
|
|
64
|
Welsh CF, Moss J, Vaughan M.
Isolation of recombinant ADP-ribosylation factor 6, an approximately 20-kDa guanine nucleotide-binding protein, in an activated GTP-bound state.
J Biol Chem 269(22): 15583-7, 1994.
[Text Abstract on PubMed]
|
|
|
65
|
Haun RS, Tsai SC, Adamik R, Moss J, Vaughan M.
Effect of myristoylation on GTP-dependent binding of ADP-ribosylation factor to Golgi.
J Biol Chem 268(10): 7064-8, 1993.
[Text Abstract on PubMed]
|
|
|
66
|
Kunz BC, Muczynski KA, Welsh CF, Stanley SJ, Tsai SC, Adamik R, Chang PP, Moss J, Vaughan M.
Characterization of recombinant and endogenous ADP-ribosylation factors synthesized in Sf9 insect cells.
Biochemistry 32(26): 6643-8, 1993.
[Text Abstract on PubMed]
|
|
|
67
|
Mishima K, Tsuchiya M, Nightingale MS, Moss J, Vaughan M.
ARD 1, a 64-kDa guanine nucleotide-binding protein with a carboxyl-terminal ADP-ribosylation factor domain.
J Biol Chem 268(12): 8801-7, 1993.
[Text Abstract on PubMed]
|
|
|
68
|
Moss J, Stanley SJ, Vaughan M, Tsuji T.
Interaction of ADP-ribosylation factor with Escherichia coli enterotoxin that contains an inactivating lysine 112 substitution.
J Biol Chem 268(9): 6383-7, 1993.
[Text Abstract on PubMed]
|
|
|
69
|
Moss J, Vaughan M.
ADP-ribosylation factors, 20,000 M(r) guanine nucleotide-binding protein activators of cholera toxin and components of intracellular vesicular transport systems.
Cell Signal 5(4): 367-79, 1993.
[Text Abstract on PubMed]
|
|
|
70
|
Moss J, Vaughan M.
ADP-ribosylation factors: protein activators of cholera toxin.
Prog Nucleic Acid Res Mol Biol 45: 47-65, 1993.
[Text Abstract on PubMed]
|
|
|
71
|
Murayama T, Tsai SC, Adamik R, Moss J, Vaughan M.
Effects of temperature on ADP-ribosylation factor stimulation of cholera toxin activity.
Biochemistry 32(2): 561-6, 1993.
[Text Abstract on PubMed]
|
|
|
72
|
Murtagh JJ, Lee FJ, Deak P, Hall LM, Monaco L, Lee CM, Stevens LA, Moss J, Vaughan M.
Molecular characterization of a conserved, guanine nucleotide-dependent ADP-ribosylation factor in Drosophila melanogaster.
Biochemistry 32(23): 6011-8, 1993.
[Text Abstract on PubMed]
|
|
|
73
|
Serventi IM, Cavanaugh E, Moss J, Vaughan M.
Characterization of the gene for ADP-ribosylation factor (ARF) 2, a developmentally regulated, selectively expressed member of the ARF family of approximately 20-kDa guanine nucleotide-binding proteins.
J Biol Chem 268(7): 4863-72, 1993.
[Text Abstract on PubMed]
|
|
|
74
|
Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.
Effects of brefeldin A and accessory proteins on association of ADP-ribosylation factors 1, 3, and 5 with Golgi.
J Biol Chem 268(15): 10820-5, 1993.
[Text Abstract on PubMed]
|
|
|
75
|
Avigan J, Murtagh JJ, Stevens LA, Angus CW, Moss J, Vaughan M.
Pertussis toxin-catalyzed ADP-ribosylation of G(o) alpha with mutations at the carboxyl terminus.
Biochemistry 31(33): 7736-40, 1992.
[Text Abstract on PubMed]
|
|
|
76
|
Lee CM, Haun RS, Tsai SC, Moss J, Vaughan M.
Characterization of the human gene encoding ADP-ribosylation factor 1, a guanine nucleotide-binding activator of cholera toxin.
J Biol Chem 267(13): 9028-34, 1992.
[Text Abstract on PubMed]
|
|
|
77
|
Lee FJ, Moss J, Vaughan M.
Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae.
J Biol Chem 267(34): 24441-5, 1992.
[Text Abstract on PubMed]
|
|
|
78
|
Moss J, Vaughan M.
Activation of cholera toxin by ADP-ribosylation factors, 20-kDa guanine nucleotide-binding proteins.
Curr Top Cell Regul 32: 49-72, 1992.
[Text Abstract on PubMed]
|
|
|
79
|
Murtagh JJ, Mowatt MR, Lee CM, Lee FJ, Mishima K, Nash TE, Moss J, Vaughan M.
Guanine nucleotide-binding proteins in the intestinal parasite Giardia lamblia. Isolation of a gene encoding an approximately 20-kDa ADP-ribosylation factor.
J Biol Chem 267(14): 9654-62, 1992.
[Text Abstract on PubMed]
|
|
|
80
|
Price SR, Nightingale MS, Bobak DA, Tsuchiya M, Moss J, Vaughan M.
Conservation of a 23-kDa human transplantation antigen in mammalian species.
Genomics 14(4): 959-64, 1992.
[Text Abstract on PubMed]
|
|
|
81
|
Serventi IM, Moss J, Vaughan M.
Enhancement of cholera toxin-catalyzed ADP-ribosylation by guanine nucleotide-binding proteins.
Curr Top Microbiol Immunol 175: 43-67, 1992.
[Text Abstract on PubMed]
|
|
|
82
|
Tsai SC, Adamik R, Haun RS, Moss J, Vaughan M.
Differential interaction of ADP-ribosylation factors 1, 3, and 5 with rat brain Golgi membranes.
Proc Natl Acad Sci U S A 89(19): 9272-6, 1992.
[Text Abstract on PubMed]
|
|
|
83
|
Walker MW, Bobak DA, Tsai SC, Moss J, Vaughan M.
GTP but not GDP analogues promote association of ADP-ribosylation factors, 20-kDa protein activators of cholera toxin, with phospholipids and PC-12 cell membranes.
J Biol Chem 267(5): 3230-5, 1992.
[Text Abstract on PubMed]
|
|
|
84
|
Welsh CF, Moss J, Vaughan M.
ADP-ribosylation factor, a guanine nucleotide-binding protein activator of cholera toxin, is isolated in an activated state when expressed as a fusion protein in Escherichia coli.
Trans Assoc Am Physicians 105: 172-6, 1992.
[Text Abstract on PubMed]
|
|
|
85
|
Moss J, Tsai SC, Price SR, Bobak DA, Vaughan M.
Soluble guanine nucleotide-dependent ADP-ribosylation factors in activation of adenylyl cyclase by cholera toxin.
Methods Enzymol 195: 243-56, 1991.
[Text Abstract on PubMed]
|
|
|
86
|
Moss J, Vaughan M.
Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20 kDa guanine nucleotide-binding proteins.
Mol Microbiol 5(11): 2621-7, 1991.
[Text Abstract on PubMed]
|
|
|
87
|
Murtagh JJ, Eddy R, Shows TB, Moss J, Vaughan M.
Different forms of Go alpha mRNA arise by alternative splicing of transcripts from a single gene on human chromosome 16.
Mol Cell Biol 11(2): 1146-55, 1991.
[Text Abstract on PubMed]
|
|
|
88
|
Tsai SC, Adamik R, Moss J, Vaughan M.
Guanine nucleotide dependent formation of a complex between choleragen (cholera toxin) a subunit and bovine brain ADP-ribosylation factor.
Biochemistry 30(15): 3697-703, 1991.
[Text Abstract on PubMed]
|
|
|
89
|
Tsai SC, Adamik R, Tsuchiya M, Chang PP, Moss J, Vaughan M.
Differential expression during development of ADP-ribosylation factors, 20-kDa guanine nucleotide-binding protein activators of cholera toxin.
J Biol Chem 266(13): 8213-9, 1991.
[Text Abstract on PubMed]
|
|
|
90
|
Tsai SC, Haun RS, Tsuchiya M, Moss J, Vaughan M.
Isolation and characterization of the human gene for ADP-ribosylation factor 3, a 20-kDa guanine nucleotide-binding protein activator of cholera toxin.
J Biol Chem 266(34): 23053-9, 1991.
[Text Abstract on PubMed]
|
|
|
91
|
Tsuchiya M, Price SR, Tsai SC, Moss J, Vaughan M.
Molecular identification of ADP-ribosylation factor mRNAs and their expression in mammalian cells.
J Biol Chem 266(5): 2772-7, 1991.
[Text Abstract on PubMed]
|
|
|
92
|
Monaco L, Murtagh JJ, Newman KB, Tsai SC, Moss J, Vaughan M.
Selective amplification of an mRNA and related pseudogene for a human ADP-ribosylation factor, a guanine nucleotide-dependent protein activator of cholera toxin.
Proc Natl Acad Sci U S A 87(6): 2206-10, 1990.
[Text Abstract on PubMed]
|
|
|
93
|
Moss J, Tsuchiya M, Tsai SC, Adamik R, Bobak DA, Price SR, Nightingale MS, Vaughan M.
Structural and functional characterization of ADP-ribosylation factors, 20 kDa guanine nucleotide-binding proteins that activate cholera toxin.
Adv Second Messenger Phosphoprotein Res 24: 83-8, 1990.
[Text Abstract on PubMed]
|
|
|
94
|
Noda M, Tsai SC, Adamik R, Moss J, Vaughan M.
Mechanism of cholera toxin activation by a guanine nucleotide-dependent 19 kDa protein.
Biochim Biophys Acta 1034(2): 195-9, 1990.
[Text Abstract on PubMed]
|
|
|
95
|
Williamson KC, Smith LA, Moss J, Vaughan M.
Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.
J Biol Chem 265(34): 20807-12, 1990.
[Text Abstract on PubMed]
|
|
|
96
|
Williamson KC, Smith LA, Moss J, Vaughan M.
Role of guanine nucleotide-binding proteins in Clostridium botulinum pathology: purification of substrates for Clostridium botulinum C3 ADP-ribosyltransferase with different requirements for GTP and phospholipids.
Trans Assoc Am Physicians 103: 281-8, 1990.
[Text Abstract on PubMed]
|
|
|
97
|
Bahnson TD, Tsai SC, Adamik R, Moss J, Vaughan M.
Microinjection of a 19-kDa guanine nucleotide-binding protein inhibits maturation of Xenopus oocytes.
J Biol Chem 264(25): 14824-8, 1989.
[Text Abstract on PubMed]
|
|
|
98
|
Noda M, Tsai SC, Adamik R, Bobak DA, Moss J, Vaughan M.
Activation of immobilized, biotinylated choleragen AI protein by a 19-kilodalton guanine nucleotide-binding protein.
Biochemistry 28(19): 7936-40, 1989.
[Text Abstract on PubMed]
|
|
|
99
|
Price SR, Tsai SC, Adamik R, Angus CW, Serventi IM, Tsuchiya M, Moss J, Vaughan M.
Expression of Go alpha mRNA and protein in bovine tissues.
Biochemistry 28(9): 3803-7, 1989.
[Text Abstract on PubMed]
|
|
|
100
|
Tsuchiya M, Price SR, Nightingale MS, Moss J, Vaughan M.
Tissue and species distribution of mRNA encoding two ADP-ribosylation factors, 20-kDa guanine nucleotide binding proteins.
Biochemistry 28(25): 9668-73, 1989.
[Text Abstract on PubMed]
|
|
|
101
|
Vaughan M, Tsai SC, Noda M, Adamik R, Moss J.
Participation of a guanine nucleotide-binding protein cascade in cholera toxin activation of adenylate cyclase.
J Mol Cell Cardiol 21 Suppl 1: 97-102, 1989.
[Text Abstract on PubMed]
|
|
|
102
|
Kincaid RL, Billingsley ML, Vaughan M.
Preparation of fluorescent, cross-linking, and biotinylated calmodulin derivatives and their use in studies of calmodulin-activated phosphodiesterase and protein phosphatase.
Methods Enzymol 159: 605-26, 1988.
[Text Abstract on PubMed]
|
|
|
103
|
Kincaid RL, Vaughan M.
Purification and properties of calmodulin-activated cyclic nucleotide phosphodiesterase from mammalian brain.
Methods Enzymol 159: 557-73, 1988.
[Text Abstract on PubMed]
|
|
|
104
|
Moss J, Vaughan M.
ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.
Adv Enzymol Relat Areas Mol Biol 61: 303-79, 1988.
[Text Abstract on PubMed]
|
|
|
105
|
Murtagh JJ, Price SR, Van Meurs KP, Angus CW, Moss J, Vaughan M.
Signal transduction by guanine nucleotide-binding proteins: possible molecular basis for multiple forms of Go alpha mRNA.
Trans Assoc Am Physicians 101: 235-41, 1988.
[Text Abstract on PubMed]
|
|
|
106
|
Price SR, Nightingale M, Tsai SC, Williamson KC, Adamik R, Chen HC, Moss J, Vaughan M.
Guanine nucleotide-binding proteins that enhance choleragen ADP-ribosyltransferase activity: nucleotide and deduced amino acid sequence of an ADP-ribosylation factor cDNA.
Proc Natl Acad Sci U S A 85(15): 5488-91, 1988.
[Text Abstract on PubMed]
|
|
|
107
|
Tsai SC, Noda M, Adamik R, Chang PP, Chen HC, Moss J, Vaughan M.
Stimulation of choleragen enzymatic activities by GTP and two soluble proteins purified from bovine brain.
J Biol Chem 263(4): 1768-72, 1988.
[Text Abstract on PubMed]
|
|
|
108
|
Elks ML, Jackson M, Manganiello VC, Vaughan M.
Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
Am J Physiol 252(3 Pt 1): C342-8, 1987.
[Text Abstract on PubMed]
|
|
|
109
|
Moore H, Vaughan M.
Cutting down trees: women, nutrition and agricultural change in the northern province of Zambia, 1920-1986.
Afr Aff (Lond) 86(345): 523-40, 1987.
[Text Abstract on PubMed]
|
|
|
110
|
Schultz AM, Tsai SC, Kung HF, Oroszlan S, Moss J, Vaughan M.
Hydroxylamine-stable covalent linkage of myristic acid in G0 alpha, a guanine nucleotide-binding protein of bovine brain.
Biochem Biophys Res Commun 146(3): 1234-9, 1987.
[Text Abstract on PubMed]
|
|
|
111
|
Tsai SC, Noda M, Adamik R, Moss J, Vaughan M.
Enhancement of choleragen ADP-ribosyltransferase activities by guanyl nucleotides and a 19-kDa membrane protein.
Proc Natl Acad Sci U S A 84(15): 5139-42, 1987.
[Text Abstract on PubMed]
|
|
|
112
|
Van Meurs KP, Angus CW, Lavu S, Kung HF, Czarnecki SK, Moss J, Vaughan M.
Deduced amino acid sequence of bovine retinal Go alpha: similarities to other guanine nucleotide-binding proteins.
Proc Natl Acad Sci U S A 84(10): 3107-11, 1987.
[Text Abstract on PubMed]
|
|
|
113
|
Angus CW, Van Meurs KP, Tsai SC, Adamik R, Miedel MC, Pan YC, Kung HF, Moss J, Vaughan M.
Identification of the probable site of choleragen-catalyzed ADP-ribosylation in a Go alpha-like protein based on cDNA sequence.
Proc Natl Acad Sci U S A 83(16): 5813-6, 1986.
[Text Abstract on PubMed]
|
|
|
114
|
Halpern JL, Tsai SC, Adamik R, Kanaho Y, Bekesi E, Kung HF, Moss J, Vaughan M.
Structural and functional characterization of guanyl nucleotide-binding proteins using monoclonal antibodies to the alpha-subunit of transducin.
Mol Pharmacol 29(5): 515-9, 1986.
[Text Abstract on PubMed]
|
|
|
115
|
Kincaid RL, Martensen TM, Vaughan M.
Modulation of calcineurin phosphotyrosyl protein phosphatase activity by calmodulin and protease treatment.
Biochem Biophys Res Commun 140(1): 320-8, 1986.
[Text Abstract on PubMed]
|
|
|
116
|
Kincaid RL, Vaughan M.
Direct comparison of Ca2+ requirements for calmodulin interaction with and activation of protein phosphatase.
Proc Natl Acad Sci U S A 83(5): 1193-7, 1986.
[Text Abstract on PubMed]
|
|
|
117
|
Chang PP, Halpern J, Sohn RL, Kanaho Y, Moss J, Vaughan M.
Coupling of receptors to signal transducing components: use of anti-idiotypic antibodies to map the specific sites of interaction of receptors and guanyl nucleotide-binding proteins.
Trans Assoc Am Physicians 98: 131-5, 1985.
[Text Abstract on PubMed]
|
|
|
118
|
Kanaho Y, Moss J, Vaughan M.
Mechanism of inhibition of transducin GTPase activity by fluoride and aluminum.
J Biol Chem 260(21): 11493-7, 1985.
[Text Abstract on PubMed]
|
|
|
119
|
Kincaid RL, Stith-Coleman IE, Vaughan M.
Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase.
J Biol Chem 260(15): 9009-15, 1985.
[Text Abstract on PubMed]
|
|
|
120
|
Moss J, Tsai SC, Bruni P, Adamik R, Kanaho Y, Hewlett EL, Vaughan M.
Pertussis toxin-catalyzed ADP-ribosylation of adenylate cyclase. Effects of guanyl nucleotides and rhodopsin.
Dev Biol Stand 61: 43-9, 1985.
[Text Abstract on PubMed]
|
|
|
121
|
Terman BI, Bitonti AJ, Moss J, Vaughan M.
Activation and stabilization of the catalytic unit of adenylate cyclase.
Biochem J 227(1): 91-7, 1985.
[Text Abstract on PubMed]
|
|
|
122
|
Tsai SC, Adamik R, Moss J, Vaughan M, Manne V, Kung HF.
Effects of phospholipids and ADP-ribosylation on GTP hydrolysis by Escherichia coli-synthesized Ha-ras-encoded p21.
Proc Natl Acad Sci U S A 82(24): 8310-4, 1985.
[Text Abstract on PubMed]
|
|
|
123
|
Vaughan M, Moss J.
Altered regulation of adenylate cyclase after toxin-catalyzed ADP-ribosylation.
Curr Top Cell Regul 27: 243-51, 1985.
[Text Abstract on PubMed]
|
|
|
124
|
West RE, Moss J, Vaughan M, Liu T, Liu TY.
Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site.
J Biol Chem 260(27): 14428-30, 1985.
[Text Abstract on PubMed]
|
|
|
125
|
Hsia JA, Moss J, Hewlett EL, Vaughan M.
ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding.
J Biol Chem 259(2): 1086-90, 1984.
[Text Abstract on PubMed]
|
|
|
126
|
Hsia JA, Moss J, Hewlett EL, Vaughan M.
Requirement for both choleragen and pertussis toxin to obtain maximal activation of adenylate cyclase in cultured cells.
Biochem Biophys Res Commun 119(3): 1068-74, 1984.
[Text Abstract on PubMed]
|
|
|
127
|
Kincaid RL, Danello MA, Osborne JC, Tkachuk VA, Vaughan M.
Calcium-dependent interaction of dansyl-calmodulin and phosphodiesterase: relationship to Ca2+ requirement for enzyme activation.
Adv Cyclic Nucleotide Protein Phosphorylation Res 16: 77-87, 1984.
[Text Abstract on PubMed]
|
|
|
128
|
Kincaid RL, Manganiello VC, Odya CE, Osborne JC, Stith-Coleman IE, Danello MA, Vaughan M.
Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain.
J Biol Chem 259(8): 5158-66, 1984.
[Text Abstract on PubMed]
|
|
|
129
|
Manganiello VC, Yamamoto T, Elks M, Lin MC, Vaughan M.
Regulation of specific forms of cyclic nucleotide phosphodiesterases in cultured cells.
Adv Cyclic Nucleotide Protein Phosphorylation Res 16: 291-301, 1984.
[Text Abstract on PubMed]
|
|
|
130
|
Moss J, Burns DL, Hsia JA, Hewlett EL, Guerrant RL, Vaughan M.
NIH conference. Cyclic nucleotides: mediators of bacterial toxin action in disease.
Ann Intern Med 101(5): 653-66, 1984.
[Text Abstract on PubMed]
|
|
|
131
|
Moss J, Vaughan M.
NAD: arginine mono-ADP-ribosyltransferases from animal cells.
Methods Enzymol 106: 430-7, 1984.
[Text Abstract on PubMed]
|
|
|
132
|
Moss J, Vaughan M.
Toxin ADP-ribosyltransferases that act on adenylate cyclase systems.
Methods Enzymol 106: 411-8, 1984.
[Text Abstract on PubMed]
|
|
|
133
|
Watkins PA, Moss J, Burns DL, Hewlett EL, Vaughan M.
Inhibition of bovine rod outer segment GTPase by Bordetella pertussis toxin.
J Biol Chem 259(3): 1378-81, 1984.
[Text Abstract on PubMed]
|
|
|
134
|
Bareis DL, Manganiello VC, Hirata F, Vaughan M, Axelrod J.
Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation, and cAMP accumulation in human fibroblasts.
Proc Natl Acad Sci U S A 80(9): 2514-8, 1983.
[Text Abstract on PubMed]
|
|
|
135
|
Burns DL, Hewlett EL, Moss J, Vaughan M.
Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells.
J Biol Chem 258(3): 1435-8, 1983.
[Text Abstract on PubMed]
|
|
|
136
|
Burns DL, Moss J, Vaughan M.
Release of guanyl nucleotides from the regulatory subunit of adenylate cyclase.
J Biol Chem 258(2): 1116-20, 1983.
[Text Abstract on PubMed]
|
|
|
137
|
Elks ML, Manganiello VC, Vaughan M.
Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone.
J Biol Chem 258(14): 8582-7, 1983.
[Text Abstract on PubMed]
|
|
|
138
|
Elks ML, Watkins PA, Manganiello VC, Moss J, Hewlett E, Vaughan M.
Selective regulation by pertussis toxin of insulin-induced activation of particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes.
Biochem Biophys Res Commun 116(2): 593-8, 1983.
[Text Abstract on PubMed]
|
|
|
139
|
Kincaid RL, Vaughan M.
Affinity chromatography of brain cyclic nucleotide phosphodiesterase using 3-(2-pyridyldithio)propionyl-substituted calmodulin linked to thiol-sepharose.
Biochemistry 22(4): 826-30, 1983.
[Text Abstract on PubMed]
|
|
|
140
|
Manganiello VC, Reed BC, Lieberman FS, Moss J, Lane MD, Vaughan M.
Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
J Cyclic Nucleotide Protein Phosphor Res 9(2): 143-54, 1983.
[Text Abstract on PubMed]
|
|
|
141
|
Roscher AA, Manganiello VC, Jelsema CL, Moss J, Vaughan M.
Regulation by bradykinin of its receptor and of receptor-mediated prostacyclin formation in cultured human fibroblasts.
Trans Assoc Am Physicians 96: 175-81, 1983.
[Text Abstract on PubMed]
|
|
|
142
|
Strewler GJ, Danello MA, Manganiello VC, Vaughan M.
Ca2+-independent cyclic GMP phosphodiesterases from rat liver and HTC hepatoma cells.
Biochem J 213(2): 379-86, 1983.
[Text Abstract on PubMed]
|
|
|
143
|
Tsai SC, Adamik R, Manganiello VC, Vaughan M.
Regulation of activity of purified guanylate cyclase from liver that is unresponsive to nitric oxide.
Biochem J 215(3): 447-55, 1983.
[Text Abstract on PubMed]
|
|
|
144
|
Yamamoto T, Manganiello VC, Vaughan M.
Purification and characterization of cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from calf liver. Effects of divalent cations on activity.
J Biol Chem 258(20): 12526-33, 1983.
[Text Abstract on PubMed]
|
|
|
145
|
Yamamoto T, Yamamoto S, Osborne JC, Manganiello VC, Vaughan M, Hidaka H.
Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
J Biol Chem 258(23): 14173-7, 1983.
[Text Abstract on PubMed]
|
|
|
146
|
Bitonti AJ, Moss J, Hjelmeland L, Vaughan M.
Resolution and activity of adenylate cyclase components in a zwitterionic cholate derivative [3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate].
Biochemistry 21(15): 3650-3, 1982.
[Text Abstract on PubMed]
|
|
|
147
|
Kincaid RL, Vaughan M, Osborne JC, Tkachuk VA.
Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I.
J Biol Chem 257(18): 10638-43, 1982.
[Text Abstract on PubMed]
|
|
|
148
|
Kruth HS, Blanchette-Mackie J, Avigan J, Gamble W, Vaughan M.
Subcellular localization and quantification of cholesterol in cultured human fibroblasts exposed to human low density lipoprotein.
J Lipid Res 23(8): 1128-35, 1982.
[Text Abstract on PubMed]
|
|
|
149
|
Moss J, Burns DL, Chang PP, Cutilletta AF, Vaughan M.
Characterization of the GTP-binding component of the adenylate cyclase system in isolated myocardial muscle cells.
J Mol Cell Cardiol 14 Suppl 3: 71-5, 1982.
[Text Abstract on PubMed]
|
|
|
150
|
Vaughan M.
Cholera and cell regulation.
Hosp Pract (Hosp Ed) 17(6): 145-52, 1982.
[Text Abstract on PubMed]
|
|
|
151
|
Gagnon C, Kelly S, Manganiello V, Vaughan M, Odya C, Strittmatter W, Hoffman A, Hirata F.
Modification of calmodulin function by enzymatic carboxylic methylation.
Nature 291(5815): 515-6, 1981.
[Text Abstract on PubMed]
|
|
|
152
|
Hirata F, del Carmine R, Nelson CA, Axelrod J, Schiffmann E, Warabi A, De Blas AL, Nirenberg M, Manganiello V, Vaughan M, Kumagai S, Green I, Decker JL, Steinberg AD.
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.
Proc Natl Acad Sci U S A 78(5): 3190-4, 1981.
[Text Abstract on PubMed]
|
|
|
153
|
Kincaid RL, Kempner E, Manganiello VC, Osborne JC, Vaughan M.
Calmodulin-activated cyclic nucleotide phosphodiesterase from brain. Relationship of subunit structure to activity assessed by radiation inactivation.
J Biol Chem 256(21): 11351-5, 1981.
[Text Abstract on PubMed]
|
|
|
154
|
Kincaid RL, Manganiello VC, Vaughan M.
Calmodulin-activated cyclic nucleotide phosphodiesterase from brain. Changes in molecular size assessed by gel filtration and electrophoresis.
J Biol Chem 256(21): 11345-50, 1981.
[Text Abstract on PubMed]
|
|
|
155
|
Moss J, Manganiello VC, Hom BE, Nakaya S, Vaughan M.
Effects of d- and l-propranolol on the responsiveness of human fibroblasts to choleragen and prostaglandin E1.
Biochem Pharmacol 30(11): 1263-9, 1981.
[Text Abstract on PubMed]
|
|
|
156
|
Moss J, Vaughan M.
Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation.
Mol Cell Biochem 37(2): 75-90, 1981.
[Text Abstract on PubMed]
|
|
|
157
|
Nakaya S, Watkins PA, Bitonti AJ, Hjelmeland LM, Moss J, Vaughan M.
GTP stabilization of adenylate cyclase activated and ADP-ribosylated by choleragen.
Biochem Biophys Res Commun 102(1): 66-74, 1981.
[Text Abstract on PubMed]
|
|
|
158
|
Tsai SC, Adamik R, Manganiello VC, Vaughan M.
Reversible inactivation of soluble liver guanylate cyclase by disulfides.
Biochem Biophys Res Commun 100(2): 637-43, 1981.
[Text Abstract on PubMed]
|
|
|
159
|
Vaughan M, Danello MA, Manganiello VC, Strewler GJ.
Regulation of cyclic nucleotide phosphodiesterase activity.
Adv Cyclic Nucleotide Res 14: 263-71, 1981.
[Text Abstract on PubMed]
|
|
|
160
|
Vaughan M, Moss J.
Mono (ADP-ribosyl)transferases and their effects on cellular metabolism.
Curr Top Cell Regul 20: 205-46, 1981.
[Text Abstract on PubMed]
|
|
|
161
|
Watkins PA, Moss J, Vaughan M.
ADP ribosylation of membrane proteins from human fibroblasts. Effect of prior exposure of cells to choleragen.
J Biol Chem 256(10): 4895-9, 1981.
[Text Abstract on PubMed]
|
|
|
162
|
Bitonti AJ, Moss J, Tandon NN, Vaughan M.
Prostaglandins increase GTP hydrolysis by membranes from human mononuclear cells.
J Biol Chem 255(5): 2026-9, 1980.
[Text Abstract on PubMed]
|
|
|
163
|
Kruth HS, Vaughan M.
Quantification of low density lipoprotein binding and cholesterol accumulation by single human fibroblasts using fluorescence microscopy.
J Lipid Res 21(1): 123-30, 1980.
[Text Abstract on PubMed]
|
|
|
164
|
Moss J, Stanley SJ, Watkins PA, Vaughan M.
ADP-ribosyltransferase activity of mono- and multi-(ADP-ribosylated) choleragen.
J Biol Chem 255(16): 7835-7, 1980.
[Text Abstract on PubMed]
|
|
|
165
|
Nakaya S, Moss J, Vaughan M.
Effects of nucleoside triphosphates on choleragen-activated brain adenylate cyclase.
Biochemistry 19(21): 4871-4, 1980.
[Text Abstract on PubMed]
|
|
|
166
|
Tsai SC, Shindo H, Manganiello VC, Adamik R, Vaughan M.
Products of reaction catalyzed by purified rat liver guanylate cyclase determined by 31p NMR spectroscopy.
Proc Natl Acad Sci U S A 77(10): 5734-7, 1980.
[Text Abstract on PubMed]
|
|
|
167
|
Watkins PA, Moss J, Vaughan M.
Effects of GTP on choleragen-catalyzed ADP ribosylation of membrane and soluble proteins.
J Biol Chem 255(9): 3959-63, 1980.
[Text Abstract on PubMed]
|
|
|
168
|
Bayer BM, Kruth HS, Vaughan M, Beaven MA.
Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin.
J Pharmacol Exp Ther 210(1): 106-11, 1979.
[Text Abstract on PubMed]
|
|
|
169
|
Kincaid RL, Vaughan M.
Sequential adsorption-electrophoresis: combined procedure for purification of calcium-dependent cyclic nucleotide phosphodiesterase.
Proc Natl Acad Sci U S A 76(10): 4903-7, 1979.
[Text Abstract on PubMed]
|
|
|
170
|
Kruth HS, Avigan J, Gamble W, Vaughan M.
Effect of cell density on binding and uptake of low density lipoprotein by human fibroblasts.
J Cell Biol 83(3): 588-94, 1979.
[Text Abstract on PubMed]
|
|
|
171
|
Moss J, Vaughan M.
Activation of adenylate cyclase by choleragen.
Annu Rev Biochem 48: 581-600, 1979.
[Text Abstract on PubMed]
|
|
|
172
|
Ross PS, Moss J, Vaughan M.
Interaction of choleragen and thyrotropin with bovine thyroid adenylate cyclase.
Endocrinology 104(4): 1036-40, 1979.
[Text Abstract on PubMed]
|
|
|
173
|
Gallin JI, Sandler JA, Clyman RI, Manganiello VC, Vaughan M.
Agents that increase cyclic AMP inhibit accumulation of cGMP and depress human monocyte locomotion.
J Immunol 120(2): 492-6, 1978.
[Text Abstract on PubMed]
|
|
|
174
|
Gamble W, Vaughan M, Kruth HS, Avigan J.
Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells.
J Lipid Res 19(8): 1068-70, 1978.
[Text Abstract on PubMed]
|
|
|
175
|
Moss J, Ross PS, Agosto G, Birken S, Canfield RE, Vaughan M.
Mechanism of action of choleragen and the glycopeptide hormones: is the nicotinamide adenine dinucleotide glycohydrolase activity observed in purified hormone preparations intrinsic to the hormone?
Endocrinology 102(2): 415-9, 1978.
[Text Abstract on PubMed]
|
|
|
176
|
Moss J, Vaughan M.
Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase.
Proc Natl Acad Sci U S A 75(8): 3621-4, 1978.
[Text Abstract on PubMed]
|
|
|
177
|
Strewler GJ, Manganiello VC, Vaughan M.
Phosphodiesterase activator from rat kidney cortex.
J Biol Chem 253(2): 390-4, 1978.
[Text Abstract on PubMed]
|
|
|
178
|
Tsai SC, Manganiello VC, Vaughan M.
Activation of kidney guanylate cyclase by cobalt.
Arch Biochem Biophys 189(1): 155-60, 1978.
[Text Abstract on PubMed]
|
|
|
179
|
Tsai SC, Manganiello VC, Vaughan M.
Purification of guanylate cyclase from rat liver supernatant.
J Biol Chem 253(23): 8542-7, 1978.
[Text Abstract on PubMed]
|
|
|
180
|
Vaughan M, Moss J.
Mechanism of action of choleragen.
J Supramol Struct 8(4): 473-88, 1978.
[Text Abstract on PubMed]
|
|
|
181
|
Clyman RI, Manganiello VC, Vaughan M.
Oxygen: influence on cyclic nucleotides and calcium sequestration in the human umbilical artery.
Chest 71(2 suppl): 247-9, 1977.
[Text Abstract on PubMed]
|
|
|
182
|
Lovell-Smith CJ, Manganiello VC, Vaughan M.
Solubilization and characterization of hormone- responsive phosphodiesterase activity of rat fat cells.
Biochim Biophys Acta 497(2): 447-58, 1977.
[Text Abstract on PubMed]
|
|
|
183
|
Moss J, Osborne JC, Fishman PH, Brewer HB, Vaughan M, Brady RO.
Effect of gangliosides and substrate analogues on the hydrolysis of nicotinamide adenine dinucleotide by choleragen.
Proc Natl Acad Sci U S A 74(1): 74-8, 1977.
[Text Abstract on PubMed]
|
|
|
184
|
Moss J, Vaughan M.
Choleragen activation of solubilized adenylate cyclase: requirement for GTP and protein activator for demonstration of enzymatic activity.
Proc Natl Acad Sci U S A 74(10): 4396-400, 1977.
[Text Abstract on PubMed]
|
|
|
185
|
Moss J, Vaughan M.
Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.
J Biol Chem 252(7): 2455-7, 1977.
[Text Abstract on PubMed]
|
|
|
186
|
Clyman RI, Manganiello VC, Lovell-Smith CJ, Vaughan M.
Calcium uptake by subcellular fractions of human umbilical artery.
Am J Physiol 231(4): 1074-81, 1976.
[Text Abstract on PubMed]
|
|
|
187
|
Fishman PH, Moss J, Vaughan M.
Uptake and metabolism of gangliosides in transformed mouse fibroblasts. Relationship of ganglioside structure to choleragen response.
J Biol Chem 251(15): 4490-4, 1976.
[Text Abstract on PubMed]
|
|
|
188
|
Manganiello VC, Lovell-Smith CJ, Vaughan M.
Effects of choleragen on hormonal responsiveness of adenylate cyclase in human fibroblasts and rat fat cells.
Biochim Biophys Acta 451(1): 62-71, 1976.
[Text Abstract on PubMed]
|
|
|
189
|
Manganiello VC, Vaughan M.
Activation and inhibition of fat cell adenylate cyclase by fluoride.
J Biol Chem 251(20): 6205-9, 1976.
[Text Abstract on PubMed]
|
|
|
190
|
Moss J, De Mello MC, Vaughan M, Beaven MA.
Effect of salicylates on histamine and L-histidine metabolism. Inhibition of imidazoleacetate phosphoribosyl transferase.
J Clin Invest 58(1): 137-41, 1976.
[Text Abstract on PubMed]
|
|
|
191
|
Moss J, Fishman PH, Manganiello VC, Vaughan M, Brady RO.
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.
Proc Natl Acad Sci U S A 73(4): 1034-7, 1976.
[Text Abstract on PubMed]
|
|
|
192
|
Moss J, Fishman PH, Richards RL, Alving CR, Vaughan M, Brady RO.
Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1.
Proc Natl Acad Sci U S A 73(10): 3480-3, 1976.
[Text Abstract on PubMed]
|
|
|
193
|
Moss J, Manganiello VC, Vaughan M.
Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase.
Proc Natl Acad Sci U S A 73(12): 4424-7, 1976.
[Text Abstract on PubMed]
|
|
|
194
|
Vaughan M.
The relationships between obsessional personality, obsessions in depression, and symptoms of depression.
Br J Psychiatry 129: 36-9, 1976.
[Text Abstract on PubMed]
|
|
|
195
|
Clyman RI, Blacksin AS, Manganiello VC, Vaughan M.
Oxygen and cyclic nucleotides in human umbilical artery.
Proc Natl Acad Sci U S A 72(10): 3883-7, 1975.
[Text Abstract on PubMed]
|
|
|
196
|
Clyman RI, Blacksin AS, Sandler JA, Manganiello VC, Vaughan M.
The role of calcium in regulation of cyclic nucleotide content in human umbilical artery.
J Biol Chem 250(12): 4718-21, 1975.
[Text Abstract on PubMed]
|
|
|
197
|
Sandler JA, Gallin JI, Vaughan M.
Effects of serotonin, carbamylcholine, and ascorbic acid on leukocyte cyclic GMP and chemotaxis.
J Cell Biol 67(2PT.1): 480-4, 1975.
[Text Abstract on PubMed]
|
|
|
198
|
Talner L, Vaughan M.
Nonobstructive renal causes of flank pain: findings on noncontrast helical CT (CT KUB).
Abdom Imaging 28(2): 210-6,
[Text Abstract on PubMed]
|
|
|